- Home
- HHH vs TFX Comparison
HHH vs TFX Comparison
Compare HHH & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HHH | TFX |
|---|---|---|
| Founded | 2010 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HHH | TFX |
|---|---|---|
| Price | $78.18 | $122.95 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 10 |
| Target Price | $90.00 | ★ $139.88 |
| AVG Volume (30 Days) | 380.8K | ★ 767.4K |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 1.12% |
| EPS Growth | ★ 234.52 | N/A |
| EPS | ★ 5.10 | N/A |
| Revenue | $1,834,033,000.00 | ★ $3,189,988,000.00 |
| Revenue This Year | N/A | $9.90 |
| Revenue Next Year | $21.07 | $10.51 |
| P/E Ratio | $15.04 | ★ N/A |
| Revenue Growth | ★ 69.81 | 5.42 |
| 52 Week Low | $61.41 | $102.58 |
| 52 Week High | $91.07 | $185.94 |
Technical Indicators
Market Signals| Indicator | HHH | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 31.48 | 52.75 |
| Support Level | $82.92 | $123.66 |
| Resistance Level | $87.00 | $127.88 |
| Average True Range (ATR) | 2.13 | 3.89 |
| MACD | -0.86 | 0.36 |
| Stochastic Oscillator | 1.67 | 38.14 |
Price Performance
Historical ComparisonAbout HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc owns, manages, and develops commercial, residential, and mixed-use real estate throughout the USA. Its portfolio is strategically positioned to meet and accelerate development based on market demand, resulting in one of the strongest real estate platforms in the country. It operates through four business segments: Operating Assets, MPCs, Strategic Developments and Seaport.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.